Clinical Cell Culture

From Wikipedia, the free encyclopedia

This article may require cleanup to meet Wikipedia's quality standards.
Please discuss this issue on the talk page or replace this tag with a more specific message.
This article has been tagged since March 2007.

An editor has expressed a concern that the subject of the article does not satisfy the notability guideline or one of the following guidelines for inclusion on Wikipedia: Biographies, Books, Companies, Fiction, Music, Neologisms, Numbers, Web content, or several proposals for new guidelines.

If you are familiar with the subject matter, please expand the article to establish its notability. The best way to address this concern is to reference published, third-party sources about the subject. If notability cannot be established, the article is more likely to be considered for deletion, per Wikipedia:Guide to deletion. (See also Wikipedia:Notability)
This article has been tagged since January 2007.

Clinical Cell Culture (C3) ASX: CCE, is a company founded by Fiona Wood which aims to develop and market spray on skin processes, especially for the treatment of skin trauma and burns victims.

It products are known as CellSpray and ReCell.

Clinical Cell Culture | C3 | is a publicly listed company on the Australian Stock Exchange(ASX), trading under the symbol CCE